Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada
journal contribution
posted on 2010-10-01, 00:00 authored by A Diamantopoulos, M Lees, P Wells, F Forster, Jaithri AnanthapavanJaithri Ananthapavan, H McDonaldCost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada
History
Journal
Thrombosis and haemostasisVolume
104Issue
4Pagination
760 - 770Publisher
Schattauer GmbHLocation
Stuttgart, GermanyPublisher DOI
ISSN
0340-6245Language
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2010, European Society of CardiologyUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC